NO |
NAME OF PRODUCT |
COMPOSITION |
GRADE |
STRENGTH |
MARKET |
1 |
ACECLOFENAC TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
2 |
ACECLOFENAC, DROTAVERINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
DROTAVERINE HYDROCHLORIDE |
I.P. |
80 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
3 |
ACECLOFENAC, PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
4 |
ACECLOFENAC, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
5 |
ACECLOFENAC, PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ACECLOFENAC |
B.P. |
100 MG |
PARACETAMOL |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
6 |
ACECLOFENAC, THIOCOLCHICOSIDE TABLETS |
EACH FILM COATED TABLETS CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
THIOCOLCHICOSIDE |
I.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
7 |
ACECLOFENAC, THIOCOLCHICOSIDE TABLETS |
EACH FILMCOATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
THIOCOLCHICOSIDE |
I.P. |
8 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOURED USED |
8 |
ACECLOFENAC, PARACETAMOL, CHLORZOXAZONE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
PARACETAMOL |
I.P. |
325 MG |
CHLORZOXAZONE |
U.S.P. |
250 MG |
EXCIPIENTS |
|
Q.S |
9 |
ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
PARACETAMOL |
I.P. |
325 MG |
SERRATIOPEPTIDASE |
I.P. |
10 MG |
(EQ.TO 20000 ENZYME ACTIVITY UNITS OF SERRATIOPEPTIDASE) |
|
|
(AS ENTERIC COATED GRANULES) |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
10 |
ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE TABLETS |
EACH FILM COATED TABLET CONTAINS |
DOMESTIC |
ACECLOFENAC |
I.P. |
100 MG |
PARACETAMOL |
I.P. |
325 MG |
SERRATIOPEPTIDASE |
I.P. |
15 MG |
(EQ.TO 30000 ENZYME ACTIVITY UNITS OF SERRATIOPEPTIDASE) |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
11 |
ACETAZOLAMIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ACETAZOLAMIDE |
B.P. |
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
12 |
ACETYLSALICYLIC ACID TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
ACETYLSALICYLIC ACID |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
13 |
ACICLOVIR TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
ACICLOVIR |
B.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
14 |
ACICLOVIR TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ACICLOVIR |
I.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
15 |
ACICLOVIR TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ACICLOVIR |
I.P. |
800 MG |
EXCIPIENTS |
|
Q.S |
16 |
ACICLOVIR DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
EXPORT |
ACICLOVIR |
B.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
17 |
ACICLOVIR DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
EXPORT |
ACICLOVIR |
B.P. |
800 MG |
EXCIPIENTS |
|
Q.S |
18 |
ALBENDAZOLE CHEWABLE TABLETS |
EACH UNCOATED CHEWABLE TABLET CONTAINS: |
EXPORT |
ALBENDAZOLE |
U.S.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
19 |
ALBENDAZOLE CHEWABLE TABLETS |
EACH UNCOATED CHEWABLE TABLET CONTAINS: |
EXPORT |
ALBENDAZOLE |
U.S.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
20 |
ALBENDAZOLE CHEWABLE TABLETS |
EACH UNCOATED CHEWABLE TABLET CONTAINS: |
DOMESTIC |
ALBENDAZOLE |
I.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
21 |
ALBENDAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
ALBENDAZOLE |
U.S.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
22 |
ALBENDAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALBENDAZOLE |
I.P. |
400 MG |
EXCIPIENTS Q.S |
|
Q.S |
23 |
ALBENDAZOLE, IVERMECTIN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALBENDAZOLE |
I.P. |
400 MG |
IVERMECTIN |
I.P. |
6 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
24 |
ALBENDAZOLE, IVERMECTIN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALBENDAZOLE |
I.P. |
400 MG |
IVERMECTIN |
I.P. |
12 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
25 |
ALPRAZOLAM DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLETCONTAINS: |
DOMESTIC |
ALPRAZOLAM |
I.P. |
0.25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
26 |
ALPRAZOLAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALPRAZOLAM |
I.P. |
0.25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
27 |
ALPRAZOLAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALPRAZOLAM |
I.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
28 |
ALPRAZOLAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALPRAZOLAM |
I.P. |
1 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
29 |
ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ALPRAZOLAM |
I.P. |
0.25 MG |
FLUOXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO FLUOXETINE |
|
20 MG |
EXCIPIENTS |
|
Q.S |
30 |
AMBROXOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
AMBROXOL HYDROCHLORIDE |
B.P. |
30 MG |
EXCIPIENTS |
|
Q.S |
31 |
AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
AMBROXOL HYDROCHLORIDE |
B.P. |
30 MG |
CETIRIZINE HYDROCHLORIDE |
B.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
32 |
AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
AMBROXOL HYDROCHLORIDE |
B.P. |
60 MG |
CETIRIZINE HYDROCHLORIDE |
B.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
33 |
AMBROXOL HYDROCHLORIDE,
CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
AMBROXOL HYDROCHLORIDE |
I.P. |
60 MG |
CETIRIZINE HYDROCHLORIDE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
34 |
AMISULPRIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
AMISULPRIDE |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
35 |
AMISULPRIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
AMISULPRIDE |
I.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
36 |
AMITRIPTYLINE HYDROCHLORIDE TABLETS |
EACH FILM COTAED TABLET CONTAINS: |
DOMESTIC |
AMITRIPTYLINE HYDROCHLORIDE |
I.P. |
|
EQ.TO AMITRIPTYLINE |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
37 |
AMITRIPTYLINE HYDROCHLORIDE TABLETS |
EACH FILM COTAED TABLET CONTAINS: |
DOMESTIC |
AMITRIPTYLINE HYDROCHLORIDE |
I.P. |
|
EQ.TO AMITRIPTYLINE |
|
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
38 |
AMITRIPTYLINE HYDROCHLORIDE, CHLORDIAZEPOXIDE
TABLETS |
EACH FILM COTAED TABLET CONTAINS: |
DOMESTIC |
CHLORDIAZEPOXIDE |
I.P. |
5 MG |
AMITRIPTYLINE HYDROCHLORIDE |
I.P. |
|
EQ.TO AMITRIPTYLINE |
|
12.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
39 |
AMITRIPTYLINE HYDROCHLORIDE, CLONAZEPAM TABLETS |
EACH FILM COTAED TABLET CONTAINS: |
DOMESTIC |
AMITRIPTYLINE HYDROCHLORIDE |
I.P. |
|
EQ.TO AMITRIPTYLINE |
|
10 MG |
CLONAZEPAM |
I.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
40 |
AMLODIPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
AMLODIPINE BESYLATE |
I.P. |
|
EQ. TO AMLODIPINE |
|
2.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
41 |
AMLODIPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
AMLODIPINE BESYLATE |
I.P. |
|
EQ. TO AMLODIPINE |
|
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
42 |
AMLODIPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
AMLODIPINE BESYLATE |
B.P. |
|
EQ.TO AMLODIPINE |
|
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
43 |
AMLODIPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
AMLODIPINE BESYLATE |
B.P. |
|
EQ.TO AMLODIPINE |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
44 |
AMLODIPINE, LISINOPRIL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
LISINOPRIL DIHYDRATE |
B.P. |
|
EQ. TO ANHYDROUS LISINOPRIL |
|
5 MG |
AMLODIPINE BESYLATE |
B.P. |
|
EQ. TO AMLODIPINE |
|
5MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
45 |
AMLODIPINE, ATENOLOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
AMLODIPINE BESYLAT |
I.P. |
|
EQ. TO AMLODIPINE |
|
5 MG |
ATENOLOL |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
46 |
AMLODIPINE, ATENOLOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
S-AMLODIPINE BESYLATE |
I.P. |
|
EQ TO S-AMLODIPINE |
|
2.5 MG |
ATENOLOL |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
47 |
AMLODIPINE, LOSARTAN POTASSIUM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
AMLODIPINE BESYLATE |
I.P. |
|
EQ TO AMLODIPINE |
|
5 MG |
LOSARTAN POTASSIUM |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
48 |
AMLODIPINE, LOSARTAN POTASSIUM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
S-AMLODIPINE BESYLATE |
I.P. |
|
EQ TO S-AMLODIPINE |
|
2.5 MG |
LOSARTAN POTASSIUM |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
49 |
AMLODIPINE, TELMISARTAN TABLETS |
EACH UNCOATED TABLET CONTAINS : |
DOMESTIC |
TELMISARTAN |
I.P. |
40 MG |
AMLODIPINE BESYLATE |
I.P. |
|
EQ TO AMLODIPINE |
|
5 MG |
EXCIPIENTS |
|
Q.S |
50 |
ARIPIPRAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ARIPIPRAZOLE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
51 |
ARIPIPRAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ARIPIPRAZOLE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
52 |
ARIPIPRAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ARIPIPRAZOLE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
53 |
ARIPIPRAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ARIPIPRAZOLE |
I.P. |
30 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
54 |
ARTEMETHER, LUMEFENTRINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
ARTEMETHER |
B.P. |
80 MG |
LUMEFANTRINE |
U.S.P. |
480 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
55 |
ARTEMETHER, LUMEFENTRINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ARTEMETHER |
I.P. |
80 MG |
LUMEFANTRINE |
I.P. |
480 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
56 |
ARTEMETHER, LUMEFENTRINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ARTEMETHER |
I.P. |
40 MG |
LUMEFANTRINE |
I.P. |
240 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
57 |
ATENOLOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ATENOLOL |
B.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
58 |
ATORVASTATIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ATORVASTATIN CALCIUM |
U.S.P. |
|
EQ. TO ATORVASTATIN |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
59 |
ATORVASTATIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ATORVASTATIN CALCIUM |
U.S.P. |
|
EQ. TO ATORVASTATIN |
|
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
60 |
ATORVASTATIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ATORVASTATIN CALCIUM |
U.S.P. |
|
EQ. TO ATORVASTATIN |
|
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
61 |
ATORVASTATIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ATORVASTATIN CALCIUM |
I.P. |
|
EQ TO ATORVASTATIN |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
62 |
ATORVASTATIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ATORVASTATIN CALCIUM |
I.P. |
|
EQ TO ATORVASTATIN |
|
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
63 |
AZITHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
AZITHROMYCIN DIHYDRATE |
U.S.P. |
|
EQ.TO AZITHROMYCIN |
|
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
64 |
AZITHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
AZITHROMYCIN DIHYDRATE |
U.S.P. |
|
EQ.TO ANHYDROUS AZITHROMYCIN |
|
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
65 |
AZITHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
AZITHROMYCIN DIHYDRATE |
I.P. |
|
EQ.TO AZITHROMYCIN |
|
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
66 |
AZITHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
AZITHROMYCIN DIHYDRATE |
I.P. |
|
EQ.TO ANHYDROUS AZITHROMYCIN |
|
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
67 |
BENDAZOLE TABLET |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
BENDAZOLE |
B.P. |
20 MG |
EXCIPIENTS |
|
Q.S |
68 |
BETAMETHASONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
BETAMETHASONE |
I.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
69 |
BETAMETHASONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
BETAMETHASONE |
I.P. |
1 MG |
EXCIPIENTS |
|
Q.S |
70 |
BISACODYL DELAY RELEASE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
BISACODYL |
U.S.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
71 |
BISACODYL TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
BISACODYL |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
72 |
BISOPROLOL FUMARATE TABLETS |
EACH UNCOATED TABLET CONATINS: |
EXPORT |
BISOPROLOL FUMARATE |
B.P. |
2.5 MG |
EXCIPIENTS |
|
Q.S |
73 |
BISOPROLOL FUMARATE TABLETS |
EACH UNCOATED TABLET CONATINS: |
EXPORT |
BISOPROLOL FUMARATE |
U.S.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
74 |
BISOPROLOL FUMARATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
BISOPROLOL FUMARATE |
U.S.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
75 |
BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
BROMHEXINE HYDROCHLORIDE |
I.P. |
4 MG |
TERBUTALINE SULPHATE |
I.P. |
2.5 MG |
GUAIPHENESIN |
I.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
76 |
BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
BROMHEXINE HYDROCHLORIDE |
I.P. |
8 MG |
TERBUTALINE SULPHATE |
I.P. |
2.5 MG |
GUAIPHENESIN |
I.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
77 |
CALCIUM GLUCONATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CALCIUM GLUCONATE |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
78 |
CALCIUM WITH CHOLECALCIFEROL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CALCIUM CARBONATE (FROM ORGANIC SOURCE OYSTER SHELL) |
B.P. |
250 MG |
CHOLECALCIFEROL |
B.P. |
125 I.U |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
79 |
CALCIUM WITH VITAMIN D3 TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CALCIUM CARBONATE |
|
1250 MG |
(FROM AN ORGANIC SOURCE OYSTER SHELL) |
|
|
EQ. TO 500 MG ELEMENTAL CALCIUM |
|
|
VITAMIN D3 |
I.P. |
250 I.U |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
80 |
CALCIUM WITH VITAMIN D3 TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CALCIUM CARBONATE (FROM ORGANIC SOURCE OYSTER SHELL) |
B.P. |
1250 MG |
EQ. TO ELEMENTAL CALCIUM |
|
500 MG |
VITAMIN D3 |
B.P. |
250 I.U |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
81 |
CALCIUM WITH MAGNESIUM, ZINC
AND VITAMIN D3 TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CALCIUM CITRATE |
U.S.P. |
1000 MG |
MAGNESIUM HYDROXIDE |
I.P. |
|
EQ. TO ELEMENTAL MAGNESIUM |
|
100 MG |
ZINC SULFATE MONOHYDRATE |
I.P. |
|
EQ TO ELEMENTAL ZINC |
|
4 MG |
VITAMIN D3 |
I.P. |
200 I.U |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
82 |
CAPTOPRIL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
CAPTOPRIL |
B.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
83 |
CARBAMAZEPINE TABLETS |
EACH UNCOATED TABLET. CONTAINS: |
EXPORT |
CARBAMAZEPINE |
B.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
84 |
CARISOPRODOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CARISOPRODOL |
I.P. |
350 MG |
EXCIPIENTS |
|
Q.S |
85 |
CETIRIZINE DI-HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CETIRIZINE DIHYDROCHLORIDE |
U.S.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOURS USED |
86 |
CETIRIZINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CETIRIZINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
87 |
CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CETIRIZINE HYDROCHLORIDE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
88 |
CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAIN |
DOMESTIC |
CETIRIZINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
89 |
CETIRIZINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CETIRIZINE HYDROCHLORIDE |
B.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
90 |
CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
EACH UNCOATED TABLET CONTAIN |
U.S.P. |
10 MG |
EXCIPIENTS |
|
|
APPROVED COLOUR USED |
91 |
CHLORAMPHENICOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CHLORAMPHENICOL |
U.S.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
92 |
CHLORDIAZEPOXIDE TABLET |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CHLORDIAZEPOXIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
93 |
CHLORDIAZEPOXIDE TABLET |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CHLORDIAZEPOXIDE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
94 |
CHLORDIAZEPOXIDE, TRIFLUOPERAZINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CHLORDIAZEPOXIDE |
I.P. |
10MG |
TRIFLUOPERAZINE HYDROCHLORIDE |
I.P. |
|
EQ TO TRIFLUOPERAZINE |
|
1 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
95 |
CHLORPHENIRAMINE MALEATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CHLORPHENIRAMINE MALEATE |
I.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
96 |
CHLORPHENIRAMINE MALEATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CHLORPHENIRAMINE MALEATE |
U.S.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
97 |
CHLORPROMAZINE HDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONATINS: |
EXPORT |
CHLORPROMAZINE HYDROCHLORIDE |
U.S.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
98 |
CINNARIZINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
CINNARIZINE |
B.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
99 |
CINNARIZINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CINNARIZINE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
100 |
CINNARIZINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CINNARIZINE |
I.P. |
75 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
101 |
CINNARIZINE, PIRACETAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CINNARIZINE |
B.P. |
25 MG |
PIRACETAM |
B.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
102 |
CINNARIZINE, DOMPERIDONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CINNARIZINE |
I.P. |
20 MG |
DOMPERIDONE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
103 |
CINNARIZINE, DOMPERIDONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CINNARIZINE |
I.P. |
75 MG |
DOMPERIDONE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
104 |
CIPROFLOXACIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CIPROFLOXACIN HYDROCHLORIDE |
I.P. |
|
EQ TO CIPROFLOXACIN |
|
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
105 |
CIPROFLOXACIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CIPROFLOXACIN HYDROCHLORIDE |
I.P. |
|
EQ TO CIPROFLOXACIN |
|
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
106 |
CIPROFLOXACIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CIPROFLOXACIN HYDROCHLORIDE |
U.S.P. |
|
EQ TO CIPROFLOXACIN |
|
250 MG |
EXCIPIENTS |
|
Q.S |
107 |
CIPROFLOXACIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CIPROFLOXACIN HYDROCHLORIDE |
U.S.P. |
|
EQ TO CIPROFLOXACIN |
|
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
108 |
CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CIPROFLOXACIN HYDROCHLORIDE |
B.P. |
|
EQ.TO CIPROFLOXACIN |
|
500 MG |
TINIDAZOLE |
B.P. |
600 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
109 |
CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CIPROFLOXACIN HYDROCHLORIDE |
I.P. |
|
EQ TO CIPROFLOXACIN |
|
500 MG |
TINIDAZOLE |
I.P. |
600 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
110 |
CIPROFLOXACIN HYDROCHLORIDE, ORNIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CIPROFLOXACIN HYDROCHLORIDE |
I.P. |
|
EQ TO CIPROFLOXACIN |
|
500 MG |
ORNIDAZOLE |
I.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
111 |
CLARITHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CLARITHROMYCIN |
U.S.P. |
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
112 |
CLARITHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
CLARITHROMYCIN |
U.S.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
113 |
CLOBAZAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLOBAZAM |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
114 |
CLOBAZAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLOBAZAM |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
115 |
CLOMIPHENE CITRATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
CLOMIPHENE CITRATE |
U.S.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
116 |
CLOMIPRAMINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CLOMIPRAMINE HYDROCHLORIDE I.P. |
I.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
117 |
CLOMIPRAMINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
CLOMIPRAMINE HYDROCHLORIDE I.P. |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
118 |
CLONAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
I.P. |
0.25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
119 |
CLONAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
I.P. |
0.50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
120 |
CLONAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
U.S.P. |
0.25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
121 |
CLONAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
U.S.P. |
0.50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
122 |
CLONAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
I.P. |
1 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
123 |
CLONAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
I.P. |
2 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
124 |
CLONAZEPAM, PAROXETINE (CONTROLLED RELEASED) TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PAROXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO PAROXETINE (AS CONTROLLED RELEASE) |
|
12.5 MG |
CLONAZEPAM (AS IMMEDIATE RELEASE) |
I.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
125 |
CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
I.P. |
0.5 MG |
PROPRANOLOL HYDROCHLORIDE |
I.P. |
20 MG |
EXCIPIENTS |
|
Q.S |
126 |
CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLONAZEPAM |
I.P. |
0.5 MG |
PROPRANOLOL HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
127 |
CLONIDINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
CLONIDINE HYDROCHLORIDE |
U.S.P. |
0.15 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
128 |
CLOTRIMAZOLE VAGINAL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLOTRIMAZOLE |
I.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
129 |
CLOZAPINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLOZAPINE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
130 |
CLOZAPINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLOZAPINE |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
131 |
CLOZAPINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CLOZAPINE |
I.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
132 |
CLOZAPINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
CLOZAPINE |
U.S.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
133 |
CYPROHEPTADINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
CYPROHEPTADINE HYDROCHLORIDE |
I.P. |
|
EQ. TO CYPROHEPTADINE (ANHYDROUS) |
|
4 MG |
EXCIPIENTS |
|
Q.S |
134 |
DEFLAZACORT TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DEFLAZACORT |
|
1 MG |
EXCIPIENTS |
|
Q.S |
135 |
DEFLAZACORT TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DEFLAZACORT |
|
6 MG |
EXCIPIENTS |
|
Q.S |
136 |
DESLORATADINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DESLORATADINE |
B.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
137 |
DESLORATADINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DESLORATADINE |
U.S.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
138 |
DESVENLAFAXINE EXTENDED RELEASE TABLETS |
EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: |
DOMESTIC |
DESVENLAFAXINE SUCCINATE |
I.P. |
|
EQ. TO DESVENLAFAXINE |
|
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
139 |
DESVENLAFAXINE EXTENDED RELEASE TABLETS |
EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: |
DOMESTIC |
DESVENLAFAXINE SUCCINATE |
I.P. |
|
EQ. TO DESVENLAFAXINE |
|
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
140 |
DEXAMETHASONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DEXAMETHASONE |
I.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
141 |
DEXAMETHASONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DEXAMETHASONE |
B.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
142 |
DEXAMETHASONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DEXAMETHASONE |
U.S.P. |
0.5 MG |
EXCIPIENTS |
|
Q.S |
143 |
DEXAMETHASONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DEXAMETHASONE |
U.S.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
144 |
DEXTROMETHORPHAN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DEXTROMETHORPHAN HYDROBROMIDE |
I.P. |
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
145 |
DEXTROMETHORPHAN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DEXTROMETHORPHAN HYDROBROMIDE |
I.P. |
30 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
146 |
DIAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DIAZEPAM |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
147 |
DIAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DIAZEPAM |
I.P. |
30 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
148 |
DICLOFENAC SODIUM TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
B.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
149 |
DICLOFENAC SODIUM TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
U.S.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
150 |
DICLOFENAC SODIUM TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
U.S.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
151 |
DICLOFENAC SODIUM SUSTAINED RELEASED TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DICLOFENAC SODIUM |
I.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
152 |
DICLOFENAC SODIUM, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
B.P. |
50 MG |
PARACEAMOL |
B.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
153 |
DICLOFENAC SODIUM, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
B.P. |
50 MG |
PARACETAMOL |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
154 |
DICLOFENAC SODIUM, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
B.P. |
50 MG |
PARACETAMOL |
B.P. |
650 MG |
EXCIPIENTS |
|
Q.S |
155 |
DICLOFENAC SODIUM, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DICLOFENAC SODIUM |
I.P. |
50 MG |
PARACEAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q. S |
156 |
DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
B.P. |
50 MG |
PARACETAMOL |
B.P. |
325 MG |
CHLORZOXAZONE |
U.S.P. |
250 MG |
EXCIPIENTS |
|
Q.S |
157 |
DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DICLOFENAC SODIUM |
I.P. |
50 MG |
PARACETAMOL |
I.P. |
325 MG |
CHLORZOXAZONE |
U.S.P |
250 MG |
EXCIPIENTS |
|
Q.S |
158 |
DICLOFENAC SODIUM, PARACETAMOL, CHLORPHENAMINE MALEATE, MAGNESIUM TRISILICATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC SODIUM |
B.P. |
50 MG |
PARACETAMOL |
B.P. |
500 MG |
CHLORPHENAMINE MALEATE |
B.P. |
4 MG |
MAGNESIUM TRISILICATE |
B.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
159 |
DICLOFENAC POTASSIUM TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC POTASSIUM |
U.S.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
160 |
DICLOFENAC POTASSIUM, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DICLOFENAC POTASSIUM |
B.P. |
50 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
161 |
DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
DICLOFENAC POTASSIUM |
B.P. |
50 MG |
PARACETAMOL |
B.P. |
325 MG |
SERRATIOPEPTIDASE |
B.P. |
15 MG |
(EQ TO 30000 ENZYME ACTIVTY UNITS OF SERRATIOPEPTIDASE) |
|
|
(AS ENTERIC COATED) |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
162 |
DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DICLOFENAC POTASSIUM |
B.P. |
50 MG |
PARACETAMOL |
I.P. |
325 MG |
SERRATIOPEPTIDASE |
I.P. |
10 MG |
(EQ TO 20000 ENZYME ACTIVTY UNITS OF SERRATIOPEPTIDASE) |
|
|
(AS ENTERIC COATED) |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
163 |
DICYCLOMINE HYDROCHLORIDE, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DICYCLOMINE HYDROCHLORIDE |
U.S.P. |
20 MG |
PARACETAMOL |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
164 |
DICYCLOMINE HYDROCHLORIDE, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DICYCLOMINE HYDROCHLORIDE |
I.P. |
20 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q. S |
165 |
DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DIETHYLCARBAMAZINE CITRATE |
I.P. |
150 MG |
CHLORPHENIRAMINE MALEATE |
I.P. |
2.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS |
166 |
DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DIETHYLCARBAMAZINE CITRATE |
I.P. |
250 MG |
CHLORPHENIRAMINE MALEATE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
167 |
DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DIETHYLCARBAMAZINE CITRATE |
I.P. |
200 MG |
CHLORPHENIRAMINE MALEATE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
168 |
DIGOXIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
DIGOXIN |
B.P. |
0.25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
169 |
DIGOXIN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DIGOXIN |
B.P. |
0.25 MG |
EXCIPIENTS |
|
Q.S |
170 |
DILUTED ISOSORBIDE MONONITRATE TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DILUTED ISOSORBIDE MONONITRATE |
I.P. |
|
EQ TO ISOSORBIDE |
|
20 MG |
EXCIPIENTS |
|
Q. S |
171 |
DIPHENOXYLATE HYDROCHLORIDE, ATROPINE SULPHATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
DIPHENOXYLATE HYDROCHLORIDE |
I.P. |
2.5 MG |
ATROPINE SULPHATE |
I.P. |
0.025 MG |
EXCIPIENTS |
|
Q. S |
172 |
DIPHENHYDRAMINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DIPHENHYDRAMINE HYDROCHLORIDE |
B.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
173 |
DIPYRIDAMOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
DIPYRIDAMOLE |
U.S.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
174 |
DIVALPROEX SODIUM EXTENDED RELEASE TABLETS |
EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: |
DOMESTIC |
DIVALPROEX SODIUM |
I.P. |
|
EQ TO VALPROIC ACID |
|
250 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
175 |
DIVALPROEX SODIUM EXTENDED RELEASE TABLETS |
EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: |
DOMESTIC |
DIVALPROEX SODIUM |
I.P. |
|
EQ TO VALPROIC ACID |
|
500 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
176 |
DOMPERIDONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
DOMPERIDONE MALEATE |
B.P. |
|
EQ TO DOMPERIDONE |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
177 |
DOMPERIDONE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
DOMPERIDONE |
B.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
178 |
DOXEPIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DOXEPIN HYDROCHLORIDE |
I.P. |
|
EQ TO DOXEPIN |
|
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
179 |
DOXEPIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DOXEPIN HYDROCHLORIDE |
I.P. |
|
EQ TO DOXEPIN |
|
75 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
180 |
DOXYLAMINE SUCCINATE, PYRIDOXINE
HYDROCHLORIDE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
DOXYLAMINE SUCCINATE |
U.S.P. |
10 MG |
PYRIDOXINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
181 |
DOXYLAMINE SUCCINATE,
PYRIDOXINE HYDROCHLORIDE, FOLIC ACID TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
DOXYLAMINE SUCCINATE |
U.S.P. |
10 MG |
PYRIDOXINE HYDROCHLORIDE |
I.P. |
10 MG |
FOLIC ACID |
I.P. |
2.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
182 |
DROTAVERINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
DROTAVERINE HYDROCHLORIDE |
B.P. |
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
183 |
DROTAVERINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DROTAVERINE HYDROCHLORIDE |
I.P. |
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
184 |
DROTAVERINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
DROTAVERINE HYDROCHLORIDE |
B.P. |
80 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
185 |
DROTAVERINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DROTAVERINE HYDROCHLORIDE |
I.P. |
80 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
186 |
DROTAVERINE HYDROCHLORIDE, PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAIN: |
DOMESTIC |
DROTAVERINE HYDROCHLORIDE |
I.P. |
80 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
187 |
DROTAVERINE HYDROCHLORIDE, MEFENAMIC ACID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DROTAVERINE HYDROCHLORIDE |
I.P. |
|
EQ. TO DROTAVERINE |
|
80 MG |
MEFENAMIC ACID |
I.P. |
250 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
188 |
DULOXETINE GASTRO-RESISTANT TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
DULOXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO DULOXETINE |
|
20 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
189 |
DULOXETINE GASTRO-RESISTANT TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
DULOXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO DULOXETINE |
|
30 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
190 |
DULOXETINE GASTRO-RESISTANT TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
DULOXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO DULOXETINE |
|
40 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
191 |
DULOXETINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DULOXETINE HYDROCHLORIDE |
U.S.P. |
|
EQ TO DULOXETINE |
|
20 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
192 |
DULOXETINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
DULOXETINE HYDROCHLORIDE |
U.S.P. |
|
EQ TO DULOXETINE |
|
30 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
193 |
ERYTHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ERYTHROMYCIN ESTOLATE |
U.S.P. |
|
EQ.TO ERYTHROMYCIN |
|
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
194 |
ERYTHROMYCIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ERYTHROMYCIN ESTOLATE |
U.S.P. |
|
EQ.TO ERYTHROMYCIN |
|
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
195 |
ESCITALOPRAM OXALATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ESCITALOPRAM OXALATE |
I.P. |
|
EQ.TO ESCITALOPRAM |
|
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
196 |
ESCITALOPRAM OXALATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ESCITALOPRAM OXALATE |
I.P. |
|
EQ.TO ESCITALOPRAM |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
197 |
ESCITALOPRAM OXALATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ESCITALOPRAM OXALATE |
I.P. |
|
EQ.TO ESCITALOPRAM |
|
20 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
198 |
ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ESCITALOPRAM OXALATE |
I.P. |
|
EQ.TO ESCITALOPRAM |
|
5 MG |
CLONAZEPAM |
I.P. |
0.50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
199 |
ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ESCITALOPRAM OXALATE |
I.P. |
|
EQ.TO ESCITALOPRAM |
|
10 MG |
CLONAZEPAM |
I.P. |
0.50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
200 |
ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ESCITALOPRAM OXALATE |
I.P. |
|
EQ.TO ESCITALOPRAM |
|
20 MG |
CLONAZEPAM |
I.P. |
0.50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
201 |
ESOMEPRAZOLE GASTRO RESISTANCE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE |
B.P. |
|
EQ TO ESOMEPRAZOLE |
|
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
202 |
ESOMEPRAZOLE GASTRO RESISTANCE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE |
B.P. |
|
EQ TO ESOMEPRAZOLE |
|
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
203 |
ESOMEPRAZOLE MAGNESIUM TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE |
I.P. |
|
EQ TO ESOMEPRAZOLE |
|
40 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
204 |
ETAMSYLATE, MEFENAMIC ACID, TRANEXAMIC ACID
TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
ETAMSYLATE |
B.P. |
250 MG |
MEFENAMIC ACID |
B.P. |
250 MG |
TRANEXAMIC ACID |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
205 |
ETHAMSYLATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ETHAMSYLATE |
B.P. |
250 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
206 |
ETIZOLAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETIZOLAM |
I.P. |
0.25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
207 |
ETIZOLAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETIZOLAM |
I.P. |
0.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
208 |
ETIZOLAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETIZOLAM |
I.P. |
1 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
209 |
ETORICOXIB TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETORICOXIB |
I.P. |
60 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
210 |
ETORICOXIB TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETORICOXIB |
I.P. |
90 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
211 |
ETORICOXIB TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETORICOXIB |
I.P. |
120 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
212 |
ETORICOXIB TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ETORICOXIB |
B.P. |
90 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
213 |
ETORICOXIB TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ETORICOXIB |
B.P. |
120 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
214 |
ETORICOXIB, THIOCOLCHICOSIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETORICOXIB |
I.P. |
60 MG |
THIOCOLCHICOSIDE |
I.P. |
4 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
215 |
FAMOTIDINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FAMOTIDINE |
B.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
216 |
FAMOTIDINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FAMOTIDINE |
B.P. |
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
217 |
FAMOTIDINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FAMOTIDINE |
B.P. |
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
218 |
FERROUS ASCORBATE, FOLIC ACID TABLETS |
EACH FILM COTAED TABLET CONTAINS: |
DOMESTIC |
FERROUS ASCORBATE |
I.P. |
|
EQ.TO ELEMENTAL IRON |
|
100 MG |
FOLIC ACID |
I.P. |
1.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
219 |
FERROUS ASCORBATE, FOLIC ACID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FERROUS FUMARATE |
I.P. |
|
EQ TO 50 MG ELEMENTAL IRON |
|
152 MG |
FOLIC ACID |
I.P. |
1.5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
220 |
FERROUS ASCORBATE, ZINC, FOLIC ACID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FERROUS ASCORBATE |
I.P. |
|
EQ TO ELEMENTAL IRON |
|
100 MG |
FOLIC ACID |
I.P. |
1.5 MG |
ZINC SULPHATE MONOHYDRATE |
I.P. |
61.8 MG |
EQ. TO 22.5 MG ELEMENTAL ZINC |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
221 |
FERROUS ASCORBATE, ZINC, FOLIC ACID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FERROUS FUMARATE |
I.P. |
150 MG |
EQ TO 50 MG ELEMENTAL IRON |
|
|
FOLIC ACID |
I.P. |
750 MCG |
ZINC SULPHATE MONOHYDRATE |
I.P. |
61.8 MG |
EQ. TO 22.5 MG ELEMENTAL ZINC |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
222 |
FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FERROUS FUMARATE |
I.P. |
300 MG |
FOLIC ACID |
I.P. |
1.5 MG |
CYANOCOBALAMIN |
I.P. |
15 MCG |
ZINC SULPHATE MONOHYDRATE |
I.P. |
61.8 MG |
EQ. TO 22.5 MG ELEMENTAL ZINC |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
223 |
FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FERROUS FUMARATE |
I.P. |
400 MG |
FOLIC ACID |
I.P. |
1.5 MG |
CYANOCOBALAMIN |
I.P. |
15 MCG |
ZINC SULPHATE MONOHYDRATE |
I.P. |
61.8 MG |
(EQ. TO 22.5 MG ELEMENTAL ZINC) |
|
|
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
224 |
FEXOFENADINE HYDROCHLORIDE DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
EXPORT |
FXOFENADINE HYDROCHLORIDE |
U.S.P. |
60 MG |
EXCIPIENTS |
|
Q.S |
225 |
FEXOFENADINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FEXOFENADINE HYDROCHLORIDE |
U.S.P. |
60 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
226 |
FEXOFENADINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FEXOFENADINE HYDROCHLORIDE |
U.S.P. |
120 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
227 |
FEXOFENADINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FEXOFENADINE HYDROCHLORIDE |
U.S.P. |
180 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
228 |
FEXOFENADINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FEXOFENADINE HYDROCHLORIDE |
I.P. |
120 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
229 |
FEXOFENADINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FEXOFENADINE HYDROCHLORIDE |
I.P. |
180 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
230 |
FEXOFENADINE HYDROCHLORIDE, MONTELUKAST TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FEXOFENADINE HYDROCHLORIDE |
I.P. |
120 MG |
MONTELUKAST SODIUM |
I.P. |
|
EQ TO MONTELUKAST |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
231 |
FLUCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
FLUCONAZOLE |
U.S.P. |
150 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
232 |
FLUCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FLUCONAZOLE |
I.P. |
150 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
233 |
FLUCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FLUCONAZOLE |
I.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
234 |
FLUCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FLUCONAZOLE |
I.P. |
300 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
235 |
FLUCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FLUCONAZOLE |
I.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
236 |
FLUNARIZINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FLUNARIZINE DIHYDROCHLORIDE |
I.P. |
|
EQ TO FLUNARIZINE |
|
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
237 |
FLUNARIZINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FLUNARIZINE DIHYDROCHLORIDE |
I.P. |
|
EQ TO FLUNARIZINE |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
238 |
FLUOXETINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
FLUOXETINE HYDROCHLORIDE |
U.S.P. |
|
EQ. TO FLUOXETINE |
|
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
239 |
FLUOXETINE HYDROCHLORIDE TABLETS |
EACH HARD GELATIN CAPSULE CONTAINS: |
DOMESTIC |
FLUOXETINE HYDROCHLORIDE |
I.P. |
|
EQ. TO FLUOXETINE |
|
20 MG |
EXCIPIENT |
|
Q. S |
APPROVED COLOUR USED |
240 |
FLUOXETINE HYDROCHLORIDE TABLETS |
EACH HARD GELATIN CAPSULE CONTAINS: |
DOMESTIC |
FLUOXETINE HYDROCHLORIDE |
I.P. |
|
EQ. TO FLUOXETINE |
|
40 MG |
EXCIPIENT |
|
Q. S |
APPROVED COLOUR USED |
241 |
FLUOXETINE HYDROCHLORIDE TABLETS |
EACH HARD GELATIN CAPSULE CONTAINS: |
DOMESTIC |
FLUOXETINE HYDROCHLORIDE |
I.P. |
|
EQ. TO FLUOXETINE |
|
60 MG |
EXCIPIENT |
|
Q. S |
APPROVED COLOUR USED |
242 |
FLUVOXAMINE MALEATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FLUVOXAMINE MALEATE |
I.P. |
50 MG |
EXCIPIENT |
|
Q. S |
APPROVED COLOUR USED |
243 |
FLUVOXAMINE MALEATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
FLUVOXAMINE MALEATE |
I.P. |
100 MG |
EXCIPIENT |
|
Q. S |
APPROVED COLOUR USED |
244 |
FLUVOXAMINE MALEATE SUSTIANED RELEASE TABLETS |
EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: |
DOMESTIC |
FLUVOXAMINE MALEATE |
I.P. |
100 MG |
EXCIPIENT |
|
Q. S |
APPROVED COLOUR USED |
245 |
FOLIC ACID TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
FOLIC ACID |
B.P. |
1 MG |
EXCIPIENTS |
|
Q.S |
246 |
FOLIC ACID TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
FOLIC ACID |
B.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
247 |
FOLIC ACID TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
FOLIC ACID |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
248 |
GLIBENCLAMIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
GLIBENCLAMIDE |
B.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
249 |
GLIMEPIRIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
GLIMEPIRIDE |
I.P. |
2 MG |
EXCIPIENTS |
|
Q. S |
250 |
GLIMEPIRIDE TABLET |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
GLIMEPIRIDE |
U.S.P. |
1 MG |
EXCIPIENTS |
|
Q.S |
251 |
GLIMEPIRIDE TABLET |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
GLIMEPIRIDE |
U.S.P. |
2 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
252 |
GLIMEPIRIDE TABLET |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
GLIMEPIRIDE |
U.S.P. |
3 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
253 |
GLIMEPIRIDE TABLET |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
GLIMEPIRIDE |
U.S.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
254 |
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
GLIMEPIRIDE |
U.S.P. |
1 MG |
METFORMIN HYDROCHLORIDE |
U.S.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
255 |
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
GLIMEPIRIDE |
U.S.P. |
2 MG |
METFORMIN HYDROCHLORIDE |
U.S.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
256 |
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
GLIMEPIRIDE |
I.P. |
1 MG |
METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) |
I.P. |
500 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
257 |
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
GLIMEPIRIDE |
I.P. |
2 MG |
METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) |
I.P. |
500 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
258 |
HALOPERIDOL TABLET |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
HALOPERIDOL |
B.P. |
5 MG |
EXCIPIENTS |
|
|
259 |
HALOPERIDOL TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
HALOPERIDOL |
I.P. |
1.5 MG |
EXCIPIENTS |
|
Q. S |
260 |
HALOPERIDOL TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
HALOPERIDOL |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
261 |
HALOPERIDOL TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
HALOPERIDOL |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
262 |
HYDROXYCHLOROQUINE SULPHATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
HYDROXYCHLOROQUINE SULPHATE |
I.P. |
200 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
263 |
HYDROXYZINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
HYDROXYZINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
264 |
HYDROXYZINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
HYDROXYZINE HYDROCHLORIDE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
265 |
IBUPROFEN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
IBUPROFEN |
B.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
266 |
IBUPROFEN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
IBUPROFEN |
B.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
267 |
IBUPROFEN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
IBUPROFEN |
I.P. |
600 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
268 |
IBUPROFEN, PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
IBUPROFEN |
B.P. |
400 MG |
PARACETAMOL |
B.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
269 |
IBUPROFEN, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
IBUPROFEN |
B.P. |
400 MG |
PARACETAMOL |
B.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
270 |
IBUPROFEN, PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
IBUPROFEN |
I.P. |
400 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
I.P. |
Q.S |
APPROVED COLOUR USED |
271 |
IMIPRAMINE HYDROCHLORIDE TABLET |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
IMIPRAMINE HYDROCHLORIDE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
272 |
IMIPRAMINE HYDROCHLORIDE TABLET |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
IMIPRAMINE HYDROCHLORIDE |
I.P. |
75 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
273 |
INDOMETHACIN TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
INDOMETHACIN |
U.S.P. |
25 MG |
EXCIPIENTS |
|
Q.S |
274 |
ISOXSUPRINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ISOXSUPRINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
275 |
ISOXSUPRINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
ISOXSUPRINE HYDROCHLORIDE |
I.P. |
20 MG |
EXCIPIENTS |
|
Q. S |
276 |
ISOXSUPRINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS |
EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: |
DOMESTIC |
ISOXSUPRINE HYDROCHLORIDE |
I.P. |
40 MG |
EXCIPIENTS |
|
Q. S |
277 |
IVERMECTIN TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
IVERMECTIN |
I.P. |
6 MG |
AQUEOUS BASE |
|
Q. S |
APPROVED COLOUR USED |
278 |
IVERMECTIN TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
IVERMECTIN |
I.P. |
12 MG |
AQUEOUS BASE |
|
Q. S |
APPROVED COLOUR USED |
279 |
KETOCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
KETOCONAZOLE |
I.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
280 |
KETOCONAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
KETOCONAZOLE |
U.S.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
281 |
KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
KETOROLAC TROMETHAMINE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
282 |
KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
EXPORT |
KETOROLAC TROMETHAMINE |
U.S.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
283 |
KETOROLAC TROMETHAMINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
KETOROLAC TROMETHAMINE |
U.S.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
284 |
KETOTIFEN FUMARATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
KETOTIFEN FUMARATE |
B.P. |
1 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
285 |
LACTIC ACID BACILLUS TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LACTIC ACID BACILLUS |
I.P. |
100 MLN SPORES |
EXCIPIENTS |
|
Q.S |
286 |
LACTIC ACID BACILLUS TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LACTIC ACID BACILLUS |
I.P. |
120 MLN SPORES |
EXCIPIENTS |
|
Q.S |
287 |
LAMOTRIGINE DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
LAMOTRIGINE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
288 |
LAMOTRIGINE DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
LAMOTRIGINE |
I.P. |
50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
289 |
LEFLUNOMIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEFLUNOMIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
290 |
LEVAMISOLE TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LEVAMISOLE HYDROCHLORIDE |
I.P. |
|
EQ TO LEVAMISOLE |
|
50 MG |
EXCIPIENTS |
|
Q. S |
291 |
LEVETIRACETAM TABLES |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVETIRACETAM |
I.P. |
250 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
292 |
LEVETIRACETAM TABLES |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVETIRACETAM |
I.P. |
500 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
293 |
LEVETIRACETAM TABLES |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVETIRACETAM |
I.P. |
1000 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
294 |
LEVETIRACETAM TABLES |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVETIRACETAM |
U.S.P. |
750 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
295 |
LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
296 |
LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
297 |
LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
LEVOCETIRIZINE DIHYDROCHLORIDE |
U.S.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
298 |
LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
299 |
LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM DISPERSIBLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
LEVOCETIRIZINE DIHYDROCHLORIDE |
U.S.P. |
5 MG |
MONTELUKAST SODIUM |
B.P. |
|
EQ. TO MONTELUKAST |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
300 |
LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
2.5 MG |
MONTELUKAST SODIUM |
I.P. |
|
EQ. TO MONTELUKAST |
|
4 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
301 |
LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST TABLETS I.P. |
EACH FILM COATED TABLET CONTAINS : |
DOMESTIC |
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 MG |
MONTELUKAST SODIUM |
I.P. |
|
EQ. TO MONTELUKAST |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
302 |
LEVOCETIRIZINE HYDROCHLORIDE, AMBROXOL HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVOCETIRIZINE HYDROCHLORIDE |
I.P. |
5 MG |
AMBROXOL HYDROCHLORIDE |
I.P. |
60 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
303 |
LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVOCETIRIZINE HYDROCHLORIDE |
I.P. |
2.5 MG |
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
304 |
LEVOFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVOFLOXACIN HEMIHYDRATE |
I.P. |
|
EQ. TO LEVOFLOXACIN |
|
250 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
305 |
LEVOFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LEVOFLOXACIN HEMIHYDRATE |
I.P. |
|
EQ. TO LEVOFLOXACIN |
|
500 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
306 |
LEVOFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
LEVOFLOXACIN HEMIHYDRATE |
U.S.P. |
|
EQ. TO LEVOFLOXACIN |
|
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
307 |
LINEZOLID TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
LINEZOLID |
I.P. |
400 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
308 |
LINEZOLID TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LINEZOLID |
I.P. |
600 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
309 |
LINEZOLID TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LINEZOLID |
I.P. |
600 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
310 |
LISINOPRIL DIHYDRATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
LISINOPRIL DIHYDRATE |
B.P. |
|
EQ TO ANHYDROUS LISINOPRIL |
|
5 MG |
EXCIPIENTS |
|
Q.S |
311 |
LISINOPRIL DIHYDRATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
LISINOPRIL DIHYDRATE |
B.P. |
|
EQ TO ANHYDROUS LISINOPRIL |
|
10 MG |
EXCIPIENTS |
|
Q.S |
312 |
LOPERAMIDE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
LOPERAMIDE HYDROCHLORIDE |
U.S.P. |
2 MG |
EXCIPIENTS |
|
Q.S |
313 |
LORATADINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
LORATADINE |
U.S.P. |
10 MG |
EXCIPIENTS |
|
Q.S |
314 |
LORAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
1 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
315 |
LORAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
2 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
316 |
LORAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
3 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
317 |
LORAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
4 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
318 |
LORAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
1 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
319 |
LORAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
2 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
320 |
LORAZEPAM MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
LORAZEPAM |
I.P. |
3 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
321 |
LOSARTAN POTASSIUM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LOSARTAN POTTASIUM |
I.P. |
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
322 |
LOSARTAN POTASSIUM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LOSARTAN POTTASIUM |
I.P. |
50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
323 |
LOSARTAN POTASSIUM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LOSARTAN POTTASIUM |
I.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
324 |
LOSARTAN POTASSIUM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
LOSARTAN POTASSIUM |
U.S.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
325 |
LOSARTAN POTASSIUM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
LOSARTAN POTASSIUM |
U.S.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
326 |
LOSARTAN POTASSIUM, HYDROCHLORTHIAZIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
LOSARTAN POTASSIUM |
I.P. |
25 MG |
HYDROCHLORTHIAZIDE |
I.P. |
12.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
327 |
MAGNESIUM LACTATE DIHYDRATE, PYRIDOXINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
MAGNESIUM LACTATE DIHYDRATE |
B.P. |
|
EQ. TO ELEMENTAL MAGNESIUM |
|
48 MG |
PYRIDOXINE HYDROCHLORIDE |
B.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
328 |
MEBENDAZOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
MEBENDAZOLE |
U.S.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
329 |
MEBHYDROLINE NAPADISYLATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
MEBHYDROLINE NAPADISYLATE |
U.S.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
330 |
MEFENAMIC ACID, DICYCLOMINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
MEFENAMIC ACID |
I.P. |
250 MG |
DICYCLOMINE HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
331 |
MELOXICAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
MELOXICAM |
B.P. |
7.5 MG |
EXCIPIENTS |
|
Q.S |
332 |
MELOXICAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
MELOXICAM |
B.P. |
15 MG |
EXCIPIENTS |
|
Q.S |
333 |
METAMIZOLE SODIUM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
METAMIZOLE SODIUM |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
334 |
METAMIZOLE SODIUM, PITOFENONE HYDROCHLORIDE, FENPIVERINIUM BROMIDE TABLETS |
EACH UNCOATED TABLET CONATINS: |
EXPORT |
METAMIZOLE SODIUM |
B.P. |
12 MG |
PITOFENONE HYDROCHLORIDE |
B.P. |
5 MG |
FENPIVERINIUM BROMIDE |
B.P. |
0.1 MG |
EXCIPIENTS |
|
Q.S |
335 |
METFORMIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
METFORMIN HYDROCHLORIDE |
U.S.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
336 |
METFORMIN HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
METFORMIN HYDROCHLORIDE |
U.S.P. |
850 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
337 |
METFORMIN HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
METFORMIN HYDROCHLORIDE |
U.S.P. |
1000 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
338 |
METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS |
EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: |
EXPORT |
METFORMIN HYDROCHLORIDE |
U.S.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
339 |
METHYLCOBALAMIN TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
METHYLCOBALAMIN |
I.P. |
5000 MCG |
EXCIPIENTS |
|
Q.S |
340 |
METHYLCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID TABLETS |
EACH UNCOATED SUBLINGUAL TABLET CONTAINS: |
DOMESTIC |
METHYLCOBALAMIN |
I.P. |
1500 MCG |
PYRIDOXINE HYDROCHLORIDE |
I.P. |
20 MG |
FOLIC ACID |
I.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
341 |
METHYLPREDNISOLONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
METHYLPREDNISOLONE |
B.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
342 |
METOCLOPRAMIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
METOCLOPRAMIDE HYDROCHLORIDE |
B.P. |
|
EQ TO METOCLOPRAMIDE |
|
10 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
343 |
METRONIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
METRONIDAZOLE |
B.P. |
250 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
344 |
METRONIDAZOLE, FURAZOLIDINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
METRONIDAZOLE |
B.P. |
400 MG |
FURAZOLIDINE |
B.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
345 |
METOPROLOL TARTRATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
METOPROLOL TARTRATE |
U.S.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
346 |
MINOCYCLINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
MINOCYCLINE HYDROCHLORIDE U.S.P. |
U.S.P. |
|
EQ TO MINOCYCLINE |
|
100 MG |
EXCIPIENTS |
|
Q. S |
347 |
MIRTAZAPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
MIRTAZAPINE |
I.P. |
7.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
348 |
MIRTAZAPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
MIRTAZAPINE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
349 |
MIRTAZAPINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
MIRTAZAPINE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
350 |
NALIDIXIC ACID TABLETS |
EACH FILM COATED TABLET.CONTAINS: |
EXPORT |
NALIDIXIC ACID |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
351 |
MULTIVITAMIN AND MINERAL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
BIOTIN |
|
30 MCG |
NIACINAMIDE |
B.P. |
12 MCG |
VITAMIN B 12 |
B.P. |
1 MCG |
VITAMIN E ACETATE (50% POWDER FORM) |
B.P. |
10 MG |
ZINC SULPHATE MONOHYDRATE |
B.P. |
|
EQ TO ELEMENTAL ZINC |
|
10 MG |
THIAMINE HYDROCHLORIDE |
B.P. |
1 MG |
MAGNESIUM SULPHATE ANHYDROUS |
B.P. |
|
EQ TO ELEMENTEL MAGNESE |
|
1.8 MG |
VITAMIN B2 |
|
1.1 MG |
COPPER SULPHATE |
B.P. |
|
EQ TO ELEMENTAL COPPER |
|
0.5 MG |
CALCIUM PANTOTHENATE |
B.P. |
5 MG |
POTASSIUM IODINE |
B.P. |
|
EQ TO ELEMENTAL IODINE |
|
150 MCG |
PYRIDOXINE HYDROCHLORIDE (VIT.B6) |
B.P. |
2 MG |
SODIUM SALENATE |
B.P. |
|
EQ TO ELEMENTAL SELENIUM |
|
25 MCG |
FOLIC ACID |
B.P. |
200 MCG |
CHROMIUM PICOLINATE |
B.P. |
|
EQ TO CHROMIUM |
|
25 MCG |
VITAMIN A |
B.P. |
200 I.U |
VITAMIN D3 |
B.P. |
400 I.U |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
352 |
NICLOSAMIDE (ANHYDROUS) TABLETS |
EACH UNCOATED CHEWABLE TABLET CONTAINS: |
EXPORT |
ANHYDROUS NICLOSAMIDE |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
353 |
NIMESULIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
NIMESULIDE |
B.P. |
100 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED NOT TO BE USED FOR CHILDREN BELOW 12 YEAR OLD |
354 |
NIMESULIDE TABLETS |
EACH UNCOATED TABLETS CONTAINS: |
DOMESTIC |
NIMESULIDE |
B.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
355 |
NIMESULIDE MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
NIMESULIDE |
B.P. |
100 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
356 |
NIMESULIDE, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
NIMESULIDE |
B.P. |
100 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
NOT TO BE USED FOR CHILDREN BELOW 12 YEAR OLD |
357 |
NITRAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
NITRAZEPAM |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
358 |
NITRAZEPAM TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
NITRAZEPAM |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
359 |
NITROXOLINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
NITROXOLINE |
B.P. |
50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
360 |
NORFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
NORFLOXACIN |
I.P. |
400 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
361 |
NORFLOXACIN, TINIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
NORFLOXACIN |
I.P. |
400 MG |
TINIDAZOLE |
I.P. |
600 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
362 |
NORTRIPTYLINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
NORTRIPTYLINE HYDROCHLORIDE |
I.P. |
|
EQ.TO NORTRIPTYLINE |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
363 |
NORTRIPTYLINE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
NORTRIPTYLINE HYDROCHLORIDE |
I.P. |
|
EQ.TO NORTRIPTYLINE |
|
50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
364 |
NYSTATIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
NYSTATIN |
B.P. |
500000 IU |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
365 |
OFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
OFLOXACIN |
I.P. |
200 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
366 |
OFLOXACIN TABLETS |
EACH FILM COATED TABET CONTAINS: |
EXPORT |
OFLOXACIN |
B.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
367 |
OFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
OFLOXACIN |
B.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
368 |
OFLOXACIN TABLETS |
EACH FILM COATED TABET CONTAINS: |
EXPORT |
OFLOXACIN |
U.S.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
369 |
OFLOXACIN TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
OFLOXACIN |
U.S.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
370 |
OFLOXACIN, ORNIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
OFLOXACIN |
I.P. |
100 MG |
ORNIDAZOLE |
I.P. |
250 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
371 |
OFLOXACIN, ORNIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
OFLOXACIN |
B.P. |
200 MG |
ORNIDAZOLE |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
372 |
OFLOXACIN, ORNIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
OFLOXACIN |
I.P. |
200 MG |
ORNIDAZOLE |
I.P. |
500 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
373 |
OFLOXACIN, TINIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
OFLOXACIN |
I.P. |
200 MG |
TINIDAZOLE |
I.P. |
600 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
374 |
OLANZAPINE MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
OLANZAPINE |
I.P. |
2.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
375 |
OLANZAPINE MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
OLANZAPINE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
376 |
OLANZAPINE MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
OLANZAPINE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
377 |
OLANZAPINE MOUTH DISSOLVING TABLETS |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
DOMESTIC |
OLANZAPINE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
378 |
OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
OMEPRAZOLE MAGNESIUM |
U.S.P. |
|
EQ TO OMEPRAZOLE |
|
10 MG |
DOMPERIDONE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
379 |
OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
OMEPRAZOLE MAGNESIUM |
I.P. |
|
EQ TO OMEPRAZOLE |
|
10 MG |
DOMPERIDONE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
380 |
OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
OMEPRAZOLE MAGNESIUM |
U.S.P. |
|
EQ TO OMEPRAZOLE |
|
10 MG |
DOMPERIDONE |
I.P. |
15 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
381 |
ONDANSETRON HYDROCHLORIDE
ORALLY DISINTEGRATING TABLETS |
EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS: |
DOMESTIC |
ONDANSETRON HYDROCHLORIDE |
I.P. |
|
EQ.TO ONDANSETRON |
|
4 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
382 |
ORNIDAZOLE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
ORNIDAZOLE |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
383 |
PANTOPRAZOLE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
DOMESTIC |
PANTOPRAZOLE SOD. SESQUIHYDRATE |
I.P. |
|
EQ TO PANTOPRAZOLE |
|
40 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
384 |
PANTOPRAZOLE GASTRO-RESISTANCE
TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
PANTOPRAZOLE SOD. SESQUIHYDRATE |
B.P. |
|
EQ TO PANTOPRAZOLE |
|
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
385 |
PANTOPRAZOLE DELAYED RELEASE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
PANTOPRAZOLE SOD. SESQUIHYDRATE |
U.S.P. |
|
EQ TO PANTOPRAZOLE |
|
20 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
386 |
PANTOPRAZOLE DELAYED RELEASE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
EXPORT |
PANTOPRAZOLE SOD. SESQUIHYDRATE |
B.P. |
|
EQ TO PANTOPRAZOLE |
|
40 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
387 |
PANTOPRAZOLE SODIUM, DOMPERIDONE TABLETS |
EACH ENTERIC COATED TABLET. CONTAINS: |
DOMESTIC |
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|
EQ.TO PANTOPRAZOLE |
|
20 MG |
DOMPERIDONE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
388 |
PANTOPRAZOLE SODIUM, DOMPERIDONE TABLETS |
EACH ENTERIC COATED TABLET. CONTAINS: |
DOMESTIC |
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|
EQ.TO PANTOPRAZOLE |
|
40 MG |
DOMPERIDONE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
389 |
PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
PARACETAMOL |
B.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
390 |
PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
PARACETAMOL |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
391 |
PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
500 MG |
EXCIPIENTS |
|
Q. S |
392 |
PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
PARACETAMOL |
B.P. |
650 MG |
EXCIPIENTS |
|
Q.S |
393 |
PARACETAMOL TABLETS |
EACH UNCOATED TABLET. CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
650 MG |
EXCIPIENTS |
|
Q.S |
394 |
PARACETAMOL TABLETS |
EACH UNCOATED TABLET. CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
1000 MG |
EXCIPIENTS |
|
Q.S |
395 |
PARACETAMOL DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
650 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
396 |
PARACETAMOL, CAFFEINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
325 MG |
CAFFEINE ANHYDROUS |
I.P. |
50 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
397 |
PARACETAMOL, CAFFEINE, ACETYLSALICYLIC ACID TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
PARACETAMOL |
B.P. |
180 MG |
CAFFEINE (ANHYDROUS) |
B.P. |
30 MG |
ACETYLSALICYLI ACID |
B.P. |
240 MG |
EXCIPIENTS |
|
Q.S |
398 |
PARACETAMOL, ETODOLAC TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETODOLAC |
I.P. |
400 MG |
PARACETAMOL |
I.P. |
200 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
399 |
PARACETAMOL, ETODOLAC TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
ETODOLAC |
I.P. |
400 MG |
PARACETAMOL |
I.P. |
325 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
400 |
PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE, CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
PARACETAMOL |
B.P. |
500 MG |
CAFFEINE (ANHYDROUS) |
B.P. |
30 MG |
PHENYLEPHRINE HYDROCHLORIDE |
B.P. |
2.5 MG |
CETIRIZINE HYDROCHLORIDE |
B.P. |
4 MG |
EXCIPIENTS |
|
Q.S |
401 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET. CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
325 MG |
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 MG |
CETIRIZINE HYDROCHLORIDE |
I.P. |
5 MG |
EXCPIENTS |
|
Q. S |
APPROVED COLOUR USED |
402 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
325 MG |
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
10 MG |
CETIRIZINE HYDROCHLORIDE |
I.P. |
5 MG |
EXCPIENTS |
|
Q. S |
APPROVED COLOUR USED |
403 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
325 MG |
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 MG |
CETIRIZINE DI- HYDROCHLORIDE |
I.P. |
5 MG |
EXCPIENTS |
|
Q. S |
APPROVED COLOUR USED |
404 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE LEVOCETIRIZINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
325 MG |
PHENYLE PHRINE HYDROCHLORIDE |
I.P. |
5 MG |
LEVOCETIRIZINE HYDROCHLORIDE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
405 |
PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
PARACETAMOL |
B.P. |
500 MG |
CAFFEINE ANHYDROUS |
B.P. |
30 MG |
PHENYEPHRINE HYDROCHLORIDE |
B.P. |
12 MG |
CHLORPHENIRAMINE MALEATE |
B.P. |
2 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
406 |
PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PARACETAMOL |
I.P. |
325 MG |
CAFFEINE ANHYDROUS |
I.P. |
30 MG |
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 MG |
DIPHENHYDRAMINE HYDROCHLORIDE |
I.P. |
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
407 |
PAROXETINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
PAROXETINE HYDROCHLORIDE HEMIHYDRATE |
U.S.P. |
|
EQ TO PAROXETINE |
|
12.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
408 |
PAROXETINE HYDROCHLORIDE
CONTROLLED RELEASE TABLETS |
EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: |
DOMESTIC |
PAROXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO PAROXETINE |
|
12.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
409 |
PAROXETINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
PAROXETINE HYDROCHLORIDE HEMIHYDRATE |
I.P. |
|
EQ TO PAROXETINE |
|
20 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
410 |
PAROXETINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
PAROXETINE HYDROCHLORIDE HEMIHYDRATE |
U.S.P. |
|
EQ TO PAROXETINE |
|
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
411 |
PAROXETINE HYDROCHLORIDE
CONTROLLED RELEASE TABLETS |
EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: |
DOMESTIC |
PAROXETINE HYDROCHLORIDE |
I.P. |
|
EQ TO PAROXETINE |
|
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
412 |
PIRACETAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
PIRACETAM |
B.P. |
400 MG |
EXCIPIENTS |
|
Q.S |
APPROVED COLOUR USED |
413 |
POTASSIUM OROTATE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
ORITIC ACID (AS POTASSIUM OROTATE) |
B.P. |
500 MG |
EXCIPIENTS |
|
Q.S |
414 |
PRAMIPEXOLE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE |
U.S.P. |
0.5 MG |
EXCIPIENTS |
|
Q. S |
415 |
PRAZIQUANTEL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PRAZIQUANTEL |
U.S.P. |
600 MG |
EXCIPIENTS |
|
Q. S |
416 |
PREDNISOLONE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
EXPORT |
PREDNISOLONE |
B.P. |
5 MG |
EXCIPIENTS |
|
Q.S |
417 |
PRIMAQUINE PHOSPHATE DISPERSIBLE TABLETS |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
PRIMAQUINE PHOSPHATE |
I.P. |
|
EQ TO PRIMAQUINE |
|
2.5 MG |
EXCIPIENTS |
|
Q. S |
418 |
PRIMAQUINE PHOSPHATE TABLETS |
EACH FILM COATED TABLET CONTAINS |
DOMESTIC |
PRIMAQUINE PHOSPHATE |
I.P. |
|
EQ TO PRIMAQUINE |
|
7.5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
419 |
PRIMAQUINE PHOSPHATE TABLETS |
EACH FILM COATED TABLET CONTAINS |
DOMESTIC |
PRIMAQUINE PHOSPHATE |
I.P. |
|
EQ TO PRIMAQUINE |
|
15 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
420 |
PROCHLORPERAZINE MALEATE TABLET |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PROCHLORPERAZINE MALEATE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
421 |
PROCHLORPERAZINE MALEATE DISPERSIBLE TABLET |
EACH UNCOATED DISPERSIBLE TABLET CONTAINS: |
DOMESTIC |
PROCHLORPERAZINE MALEATE |
I.P. |
5 MG |
EXCIPIENTS |
|
Q. S |
422 |
PROMETHAZINE HYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
EXPORT |
PROMETHAZINE HYDROCHLORIDE |
B.P. |
25 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
423 |
PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE |
I.P. |
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
424 |
PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE |
I.P. |
20 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
425 |
PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS |
EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE |
I.P. |
20 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
426 |
PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS |
EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE |
I.P. |
40 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
427 |
PROPRANOLOL HYDROCHLORIDE (EXTENDED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) |
I.P. |
40 MG |
FLUNARIZINE DIHYDROCHLORIDE |
I.P. |
|
EQ TO FLUNARIZINE |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
427 |
PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) |
I.P. |
40 MG |
FLUNARIZINE DIHYDROCHLORIDE |
B.P. |
|
EQ TO FLUNARIZINE |
|
5 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
428 |
PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) |
I.P. |
40 MG |
FLUNARIZINE DIHYDROCHLORIDE |
B.P. |
|
EQ TO FLUNARIZINE |
|
10 MG |
EXCIPIENTS |
|
Q. S |
APPROVED COLOUR USED |
428 |
PYRIDOXINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
DOMESTIC |
PYRIDOXINE HYDROCHLORIDE |
I.P. |
50 MG |
EXCIPIENTS |
|
Q.S |
429 |
QUETIAPINE TABLET |
EACH FILM COATED TABLET CONTAINS: |
DOMESTIC |
|